These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 17904790

  • 21. Sex steroid-producing enzymes in human breast cancer.
    Suzuki T, Miki Y, Nakamura Y, Moriya T, Ito K, Ohuchi N, Sasano H.
    Endocr Relat Cancer; 2005 Dec; 12(4):701-20. PubMed ID: 16322318
    [Abstract] [Full Text] [Related]

  • 22. Intratumoral estrogen production in breast carcinoma: significance of aromatase.
    Suzuki T, Miki Y, Ohuchi N, Sasano H.
    Breast Cancer; 2008 Dec; 15(4):270-7. PubMed ID: 18622573
    [Abstract] [Full Text] [Related]

  • 23. Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results.
    Bundred NJ, Campbell ID, Davidson N, DeBoer RH, Eidtmann H, Monnier A, Neven P, von Minckwitz G, Miller JC, Schenk NL, Coleman RE.
    Cancer; 2008 Mar 01; 112(5):1001-10. PubMed ID: 18205185
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Lack of complete cross-resistance between different aromatase inhibitors; a real finding in search for an explanation?
    Lønning PE.
    Eur J Cancer; 2009 Mar 01; 45(4):527-35. PubMed ID: 19062270
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cancer treatment-induced bone loss in breast and prostate cancer.
    Saad F, Adachi JD, Brown JP, Canning LA, Gelmon KA, Josse RG, Pritchard KI.
    J Clin Oncol; 2008 Nov 20; 26(33):5465-76. PubMed ID: 18955443
    [Abstract] [Full Text] [Related]

  • 40. Effects of third generation aromatase inhibitors on bone health and other safety parameters: results of an open, randomised, multi-centre study of letrozole, exemestane and anastrozole in healthy postmenopausal women.
    McCloskey EV, Hannon RA, Lakner G, Fraser WD, Clack G, Miyamoto A, Finkelman RD, Eastell R.
    Eur J Cancer; 2007 Nov 20; 43(17):2523-31. PubMed ID: 18029171
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.